Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Topiramate in European-American Heavy Drinkers
NCT02371889Phase 2Completed
- Sponsor
- University of Pennsylvania
- Start
- Dec 2014
- Primary completion
- Feb 2020
- Modality
- Small Molecules
- Countries
- 1
01
Overview
Phase 2, randomised, double-blind trial in alcohol use disorder (AUD) comparing Topiramate + Medical Management with Placebo + Medical Management (2 arms). Primary endpoints: Frequency of Heavy Drinking Days at 12 weeks, Frequency of Heavy Drinking Days Per Day at 12 weeks and 1 more. Started Dec 2014; status: completed.
02
Drugs
topiramate
03
Conditions
alcohol use disorder (AUD)
Beyond the preview
Go deeper on NCT02371889.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT02371889.